药明康德欲在波士顿和旧金山设立新的办事处
2014年12月15日，药明康德宣布将在2015年初于波士顿和旧金山设立两家新的办事处。新的办事处将使公司不管是作为客户还是投资方，都能够更便利地接触位于世界上两个领先生物科技中心的创新公司。早在10月份，药明康德就宣布在以色列设立办事处以拓展那里的生物科技业务。公司现在已经在美国的圣保罗、费城、亚特兰大、普莱恩斯伯勒（新泽西）和圣迭戈拥有机构。
药明康德董事长兼CEO李革博士说：“我们的目标是让任何人、任何公司能够发明和开发医疗设备来造福全世界的患者，这些新的办事处使我们的综合研发平台更贴近于那儿的企业家和前沿科技。
WuXi Opening Offices in Boston and San Francisco
SHANGHAI, Dec. 15, 2014 /PRNewswire/ --WuXi PharmaTech (Cayman) Inc. (WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced that it will open offices in Boston and San Francisco in early 2015. These new offices will give the company greater access to innovative companies in the world's two leading biotech hubs, both as customers and as investments.
In October, WuXi announced that it had opened an office in Israel to tap into the biotech community there.
In addition, the company has U.S. facilities in St. Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego.
"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.
"These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where is being done."
-
焦点事件
-
焦点事件
-
焦点事件
-
焦点事件
